NNG.WA
Price:
$2.8
Market Cap:
$90.06M
NanoGroup S.A. operates as a biotechnology company. It develops and licenses early-stage biotechnology and medical projects in the areas of oncology, transplantology, and blood donations to international biotech companies and pharmaceutical companies. NanoGroup S.A was incorporated in 2016 and is based in Warsaw, Poland.
Industry
Biotechnology
IPO Date
2018-03-14
Stock Exchange
WSE
Ticker
NNG.WA
According to NanoGroup S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 1.40. This represents a change of -73.77% compared to the average of 5.34 of the last 4 quarters.
The mean historical Current Ratio of NanoGroup S.A. over the last ten years is 8.08. The current 1.40 Current Ratio has changed 1.63% with respect to the historical average. Over the past ten years (40 quarters), NNG.WA's Current Ratio was at its highest in in the December 2020 quarter at 14.22. The Current Ratio was at its lowest in in the March 2017 quarter at 0.
Average
8.08
Median
3.42
Minimum
0.56
Maximum
33.09
Discovering the peaks and valleys of NanoGroup S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.00%
Maximum Annual Current Ratio = 33.09
Minimum Annual Increase = -92.54%
Minimum Annual Current Ratio = 0.56
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 11.78 | 2.00% |
| 2023 | 0.56 | -72.73% |
| 2022 | 2.06 | 82.28% |
| 2021 | 1.13 | -92.06% |
| 2020 | 14.22 | 229.79% |
| 2019 | 4.31 | -50.24% |
| 2018 | 8.66 | 243.45% |
| 2017 | 2.52 | 2.16% |
| 2016 | 2.47 | -92.54% |
| 2015 | 33.09 | -52.51% |
The current Current Ratio of NanoGroup S.A. (NNG.WA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.80
5-year avg
5.95
10-year avg
8.08
NanoGroup S.A.’s Current Ratio is less than Genomtec S.A. (3.08), less than Urteste S.A. (10.31), less than Pharmena S.A. (13.18), greater than Pure Biologics Spólka Akcyjna (0.13), less than Poltreg S.A. (3.09), less than Medinice S.A. (1.82), greater than Mabion S.A. (0.82), less than Molecure S.A. (10.28), less than BioMaxima S.A. (1.44), greater than Airway Medix S.A. (0.12),
| Company | Current Ratio | Market cap |
|---|---|---|
| 3.08 | $66.21M | |
| 10.31 | $51.73M | |
| 13.18 | $33.97M | |
| 0.13 | $33.57M | |
| 3.09 | $122.18M | |
| 1.82 | $99.27M | |
| 0.82 | $129.30M | |
| 10.28 | $150.20M | |
| 1.44 | $48.22M | |
| 0.12 | $36.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NanoGroup S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NanoGroup S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is NanoGroup S.A.'s Current Ratio?
How is the Current Ratio calculated for NanoGroup S.A. (NNG.WA)?
What is the highest Current Ratio for NanoGroup S.A. (NNG.WA)?
What is the 3-year average Current Ratio for NanoGroup S.A. (NNG.WA)?
What is the 5-year average Current Ratio for NanoGroup S.A. (NNG.WA)?
How does the current Current Ratio for NanoGroup S.A. (NNG.WA) compare to its historical average?